BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32036793)

  • 21. An expert review of clozapine in Eastern European countries: Use, regulations and pharmacovigilance.
    Sagud M; Breznoscakova D; Celofiga A; Chihai J; Chkonia E; Ristic Ignjatovic D; Injac Stevovic L; Kopecek M; Kurvits K; Kuzo N; Lazáry J; Mazaliauskienė R; Mladina Perisa D; Novotni A; Panov G; Pikirenia U; Rădulescu FȘ; Sukiasyan SG; Taube M; Tomori S; Wilkowska A; De Las Cuevas C; Sanz EJ; de Leon J
    Schizophr Res; 2024 Jun; 268():53-59. PubMed ID: 37783650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reporting of clozapine-induced gastrointestinal hypomotility and factors associated with fatal outcomes in Canada: A pharmacovigilance database study.
    Liu CL; Maruf AA; Bousman CA
    Psychiatry Res; 2020 Aug; 290():113048. PubMed ID: 32474068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reporting Patterns of Sialorrhea Comparing Users of Clozapine to Users of Other Antipsychotics: A Disproportionality Analysis Using VigiBase.
    Man WH; Wilting I; Souverein P; Meyboom R; Egberts T; Heerdink ER
    J Clin Psychopharmacol; 2020; 40(3):283-286. PubMed ID: 32332463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nocturnal enuresis in patients taking clozapine, risperidone, olanzapine and quetiapine: comparative cohort study.
    Harrison-Woolrych M; Skegg K; Ashton J; Herbison P; Skegg DC
    Br J Psychiatry; 2011 Aug; 199(2):140-4. PubMed ID: 21653944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clozapine-Induced Gastrointestinal Hypomotility: A 22-Year Bi-National Pharmacovigilance Study of Serious or Fatal 'Slow Gut' Reactions, and Comparison with International Drug Safety Advice.
    Every-Palmer S; Ellis PM
    CNS Drugs; 2017 Aug; 31(8):699-709. PubMed ID: 28623627
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association of clozapine and haematological malignancies needs to be replicated by other studies and more importantly by analyses of subsamples from VigiBase.
    de Leon J; De Las Cuevas C; Sanz EJ; Verdoux H
    Psychol Med; 2021 Jun; 51(8):1405-1406. PubMed ID: 32372739
    [No Abstract]   [Full Text] [Related]  

  • 27. Clozapine-induced myocarditis in children and adolescents: a pharmacovigilance study using VigiBase and a systematic literature review.
    De Las Cuevas C; Arrojo-Romero M; Ruan CJ; Schoretsanitis G; Sanz EJ; de Leon J
    Expert Opin Drug Metab Toxicol; 2022 Nov; 18(11):715-727. PubMed ID: 36526610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atypical Antipsychotic Administration in Schizophrenic Patients Leads to Elevated Lipoprotein-Associated Phospholipase A2 Levels and Increased Cardiovascular Risk: A Retrospective Cohort Study.
    Shen H; Wu D; Wang S; Zhao M; Sun W; Zhu X; Zhang N; Yao H; Cui Q; Xiao H
    Basic Clin Pharmacol Toxicol; 2018 Dec; 123(6):756-765. PubMed ID: 29938908
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Second-generation antipsychotic medications and risk of pneumonia in schizophrenia.
    Kuo CJ; Yang SY; Liao YT; Chen WJ; Lee WC; Shau WY; Chang YT; Tsai SY; Chen CC
    Schizophr Bull; 2013 May; 39(3):648-57. PubMed ID: 22282455
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rhabdomyolysis reported for children and adolescents treated with antipsychotic medicines: a case series analysis.
    Star K; Iessa N; Almandil NB; Wilton L; Curran S; Edwards IR; Wong IC
    J Child Adolesc Psychopharmacol; 2012 Dec; 22(6):440-51. PubMed ID: 23234587
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A safety signal of somnambulism with the use of antipsychotics and lithium: A pharmacovigilance disproportionality analysis.
    Gouverneur A; Ferreira A; Morival C; Pageot C; Tournier M; Pariente A
    Br J Clin Pharmacol; 2021 Oct; 87(10):3971-3977. PubMed ID: 33713370
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electroencephalogram Modifications Associated With Atypical Strict Antipsychotic Monotherapies.
    Dias Alves M; Micoulaud-Franchi JA; Simon N; Vion-Dury J
    J Clin Psychopharmacol; 2018 Dec; 38(6):555-562. PubMed ID: 30247179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Statins and erectile dysfunction: results of a case/non-case study using the French Pharmacovigilance System Database.
    Do C; Huyghe E; Lapeyre-Mestre M; Montastruc JL; Bagheri H
    Drug Saf; 2009; 32(7):591-7. PubMed ID: 19530745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectrum of haematologic malignancies and survival outcomes of adult lymphomas in Maiduguri, north eastern Nigeria--a fourteen year review.
    Kagu MB; Ahmed SG; Bukar AA; Mohammed AA; Mayun AA; Musa AB
    Afr J Med Med Sci; 2013 Mar; 42(1):5-14. PubMed ID: 23909089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of anticancer drugs associated with atrial fibrillation: analysis of the WHO pharmacovigilance database.
    Alexandre J; Salem JE; Moslehi J; Sassier M; Ropert C; Cautela J; Thuny F; Ederhy S; Cohen A; Damaj G; Vilque JP; Plane AF; Legallois D; Champ-Rigot L; Milliez P; Funck-Brentano C; Dolladille C
    Eur Heart J Cardiovasc Pharmacother; 2021 Jul; 7(4):312-320. PubMed ID: 32353110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clozapine-associated myocarditis in the World Health Organization's pharmacovigilance database: Focus on reports from various countries.
    De Las Cuevas C; Sanz EJ; Ruan CJ; de Leon J
    Rev Psiquiatr Salud Ment (Engl Ed); 2022; 15(4):238-250. PubMed ID: 36513400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Escaping the Long Shadow Cast by Agranulocytosis: Reflections on Clozapine Pharmacovigilance Focused on the United Kingdom.
    de Leon J; Arrojo-Romero M; Verdoux H; Ruan CJ; Schoretsanitis G; Rohde C; Cohen D; Schulte PFJ; Kim SH; Cotes RO; Leung JG; Otsuka Y; Kirilochev OO; Baptista T; Grover S; Every-Palmer S; Clark SR; McGrane IR; Motuca M; Olmos I; Wilkowska A; Sagud M; Anil Yağcioğlu AE; Ristic DI; Lazary J; Sanz EJ; De Las Cuevas C
    J Clin Psychopharmacol; 2023 May-Jun 01; 43(3):239-245. PubMed ID: 37068034
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Treatment-resistant schizophrenia: Neutropenia with olanzapine and clozapine, and stabilization with two depot antipsychotics].
    Alba P
    Vertex; 2017 Mar; 28(132):141-144. PubMed ID: 29522636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Abuse and misuse of second-generation antipsychotics: An analysis using VigiBase, the World Health Organisation pharmacovigilance database.
    Roy S; Charreteur R; Peries M; Kheloufi F; Eiden C; Nagot N; Donnadieu-Rigole H; Micallef J; Peyrière H
    Br J Clin Pharmacol; 2022 Oct; 88(10):4646-4653. PubMed ID: 35633029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. There Is Life After the UK Clozapine Central Non-Rechallenge Database.
    Oloyede E; Casetta C; Dzahini O; Segev A; Gaughran F; Shergill S; Mijovic A; Helthuis M; Whiskey E; MacCabe JH; Taylor D
    Schizophr Bull; 2021 Jul; 47(4):1088-1098. PubMed ID: 33543755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.